IL86108A0 - Dihydropyridine derivatives and pharmaceutical compositions containing them - Google Patents

Dihydropyridine derivatives and pharmaceutical compositions containing them

Info

Publication number
IL86108A0
IL86108A0 IL86108A IL8610888A IL86108A0 IL 86108 A0 IL86108 A0 IL 86108A0 IL 86108 A IL86108 A IL 86108A IL 8610888 A IL8610888 A IL 8610888A IL 86108 A0 IL86108 A0 IL 86108A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
dihydropyridine derivatives
dihydropyridine
derivatives
Prior art date
Application number
IL86108A
Other languages
English (en)
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of IL86108A0 publication Critical patent/IL86108A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
IL86108A 1987-04-21 1988-04-19 Dihydropyridine derivatives and pharmaceutical compositions containing them IL86108A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878709447A GB8709447D0 (en) 1987-04-21 1987-04-21 Dihydropyridines

Publications (1)

Publication Number Publication Date
IL86108A0 true IL86108A0 (en) 1988-11-15

Family

ID=10616115

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86108A IL86108A0 (en) 1987-04-21 1988-04-19 Dihydropyridine derivatives and pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US4957930A (xx)
EP (1) EP0295769A3 (xx)
JP (1) JPS63280062A (xx)
KR (1) KR880012554A (xx)
CN (1) CN88102381A (xx)
AU (1) AU592498B2 (xx)
CS (1) CS270242B2 (xx)
DD (1) DD273437A5 (xx)
DK (1) DK213988A (xx)
FI (1) FI881824A (xx)
GB (1) GB8709447D0 (xx)
HU (1) HUT46894A (xx)
IL (1) IL86108A0 (xx)
NO (1) NO881709L (xx)
NZ (1) NZ224298A (xx)
PL (1) PL271920A1 (xx)
PT (1) PT87272A (xx)
YU (1) YU78388A (xx)
ZA (1) ZA882765B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2014089C (en) * 1989-07-21 1997-01-14 Vernon L. Lamb Apparatus and method for making pressboard from poly-coated paper using relative movement of facing webs
CN103274993A (zh) * 2013-06-13 2013-09-04 南京工业大学 二氢吡啶和吡咯类杂环的新合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
GB8412208D0 (en) * 1984-05-12 1984-06-20 Pfizer Ltd Quinolone inotropic agents
IL78642A0 (en) * 1985-05-03 1986-08-31 Pfizer Dihydropyridines and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
HUT46894A (en) 1988-12-28
DD273437A5 (de) 1989-11-15
PT87272A (pt) 1989-05-12
US4957930A (en) 1990-09-18
YU78388A (en) 1990-04-30
ZA882765B (en) 1989-12-27
CN88102381A (zh) 1988-11-09
NZ224298A (en) 1990-03-27
FI881824A (fi) 1988-10-22
EP0295769A2 (en) 1988-12-21
PL271920A1 (en) 1989-03-20
FI881824A0 (fi) 1988-04-19
AU592498B2 (en) 1990-01-11
JPS63280062A (ja) 1988-11-17
CS273488A2 (en) 1989-10-13
CS270242B2 (en) 1990-06-13
AU1478788A (en) 1988-10-27
DK213988A (da) 1988-10-22
EP0295769A3 (en) 1989-02-08
KR880012554A (ko) 1988-11-28
NO881709D0 (no) 1988-04-20
GB8709447D0 (en) 1987-05-28
NO881709L (no) 1988-10-24
DK213988D0 (da) 1988-04-20

Similar Documents

Publication Publication Date Title
NZ222756A (en) Tetrahydropyridine derivatives and pharmaceutical compositions
NZ220345A (en) Imidazoquinolinylether derivatives and pharmaceutical compositions containing them
IL88988A0 (en) Didehydro-vitamin d3 derivatives and pharmaceutical compositions containing them
NZ220880A (en) Di-tert-butyl-phenol derivatives and pharmaceutical compositions
IL88765A0 (en) Adenosine derivatives and pharmaceutical compositions containing them
IL86502A0 (en) Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives and pharmaceutical compositions containing them
NZ221996A (en) Imidazo-pyridine derivatives and pharmaceutical compositions
NZ224714A (en) Substituted benzotriazole derivatives and pharmaceutical compositions
IL88184A0 (en) Tetrahydropyridine derivatives,their preparation and pharmaceutical compositions containing them
NZ220171A (en) Dihydro-benzopyran derivatives and pharmaceutical compositions
NZ222155A (en) Piperidine derivatives and pharmaceutical compositions
NZ221621A (en) Piperidine derivatives and pharmaceutical compositions
NZ226002A (en) Peptidylheterocyclic compounds and pharmaceutical compositions
NZ213821A (en) Piperidine derivatives and pharmaceutical compositions
NZ227036A (en) Quinoline derivatives and pharmaceutical compositions containing such
NZ226445A (en) Aminopyridine derivatives and pharmaceutical compositions containing such
NZ228098A (en) Quinoline derivatives and pharmaceutical compositions
IL82205A0 (en) Substituted alkanesulfonamidophenyl derivatives and pharmaceutical compositions containing them
IL85969A0 (en) Ribofuranuronic acid derivatives and pharmaceutical compositions containing them
NZ221284A (en) Dihydropyridine derivatives and pharmaceutical compositions
NZ226450A (en) Crystalline-1-carbacephalosporin and pharmaceutical compositions
PH24992A (en) Alkadiene derivatives and pharmaceutical composition containing them
NZ225613A (en) Benzazepin-2-one derivatives and pharmaceutical compositions
GB2142021B (en) 1 4-dihydropyridine derivatives their preparation and pharmaceutical compositions containing them
ZA86301B (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them